Prax­is stock tanks af­ter mid-stage move­ment dis­or­der tri­al miss

3 years ago
R&D

Sum­mit clos­es $500M raise, de­spite low­er mar­ket cap; Rev­o­lu­tion rais­es $300M in stock sale

3 years ago
News Briefing

Tem­pus founders build a drug dis­cov­ery start­up, Pathos AI, with $40M in sight

3 years ago
Financing
Startups

Sang­amo scraps pub­lic of­fer­ing ‘af­ter eval­u­at­ing mar­ket con­di­tions’

3 years ago
Financing

‘Hard­er to find homes’: Lat­est wave of biotech lay­offs could test the in­dus­try

3 years ago
People
In Focus

FDA re­jects Covid-19 drug over un­cer­tain­ties around small tri­al

3 years ago
FDA+
Coronavirus

Chan Zucker­berg Ini­tia­tive an­nounces Chica­go bio­hub to study tis­sue in­flam­ma­tion

3 years ago
Discovery
Pharma

Roche, Ex­elix­is' Tecen­triq/Cabome­tyx com­bo flunks sec­ond PhI­II

3 years ago
R&D

Kymer­a's top drug hunter leaves for Alex­is Borisy's Curie.Bio; What’s done is Dunn: FDA neu­ro­science leader bows ...

3 years ago
Peer Review

Q&A with Ul­tragenyx CEO: Time to in­crease the use of ac­cel­er­at­ed ap­provals for rare dis­ease drugs

3 years ago
Pharma

House over­sight chair calls for in­ves­ti­ga­tion in­to PBM­s' tac­tics to in­crease drug costs

3 years ago
Pharma

Pub­li­cis Health aims to sort phar­ma mar­ket­ing da­ta with new ad­vi­so­ry and in­sights busi­ness

3 years ago
Pharma
Marketing

US spent near­ly $32B in pub­lic funds on mR­NA vac­cine de­vel­op­ment, study finds

3 years ago
Pharma

Sen­ate health com­mit­tee chair de­mands No­vo, Sanofi drop in­sulin costs af­ter Lil­ly

3 years ago
People
Pharma

Cana­di­an CD­MO Atom­Vie, armed with $40M Se­ries A, read­ies new man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Manufacturing

Man­u­fac­tur­ing roundup: Actylis opens the doors to a fa­cil­i­ty in Ore­gon; Emer­gent re­ports Q4 num­bers

3 years ago
Manufacturing

BioN­Tech to ex­pand pres­ence in Is­rael with man­u­fac­tur­ing and re­search site

3 years ago
Pharma
Manufacturing

In­tel­lia gets FDA clear­ance to start hered­i­tary an­gioede­ma gene edit­ing tri­al in US

3 years ago
R&D

Val­ne­va re­ports more da­ta on Covid-19 vac­cine; Clin­Choice buys a CRO

3 years ago
News Briefing

Shang­hai's Ab­bisko out-li­cens­es EGFR can­di­date in po­ten­tial­ly nine-fig­ure deal

3 years ago
Deals
China

'Y­ou are not the drug spon­sor': FDA de­clines pe­ti­tion to anoint Cas­sava's drug as 'break­through'

3 years ago
FDA+

FDA sched­ules ad­vi­so­ry com­mit­tee hear­ing for Lyn­parza prostate can­cer ap­pli­ca­tion

3 years ago
Pharma
FDA+

Ako­rn Phar­ma­ceu­ti­cals files for bank­rupt­cy, clos­es fa­cil­i­ties and will liq­ui­date

3 years ago
People
Pharma

FDA adopts ICH guid­ance on con­tin­u­ous man­u­fac­tur­ing

3 years ago
Pharma
FDA+
First page Previous page 380381382383384385386 Next page Last page
A service from the Financial Times